Eli Lilly will acquire a Wisconsin-based injectable manufacturing facility from Nexus Pharmaceuticals, a drugmaker in Illinois. The site in Pleasant Prairie, Wis., will expand Eli Lilly’s global ...

Sharp is looking to cut into the growing sterile injectables market by expanding its capacity for secondary packaging at its Pennsylvania facility. (iStock / Getty Images Plus) Sharp is honing its ...

As the United Kingdom juggles industry concerns about the region’s waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the British government first unveiled ...

Eli Lilly plans to invest more than $3.5 billion in a new injectable medicine and device manufacturing facility in Pennsylvania. The Lehigh Valley site will manufacture next-generation weight-loss ...

CHANGHUA, TAIWAN, May 29, 2026 /EINPresswire.com/ — As global demand for high-quality medical devices and precision healthcare components continues to rise, THY ...

The U.S. Food and Drug Administration said Pfizer Inc's process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas, was "out of control" and put patients at risk, according to ...

WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...

In today’s competitive and environmentally-conscious manufacturing landscape, companies are increasingly seeking innovative solutions that improve efficiency, reduce waste, and enhance sustainability.

Fictiv, a global manufacturing and supply chain company, has unveiled significant advances in its injection molding capabilities, solidifying its position as a reliable and user-friendly partner for ...